Percheron Therapeutics Limited
PERCF
$0.0025
-$0.0165-86.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.78M | -2.86M | -2.36M | -2.36M | -1.55M |
| Total Depreciation and Amortization | 11.80K | 12.10K | 10.60K | 10.50K | 15.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.30K | 10.50K | 81.90K | 81.70K | -16.30K |
| Change in Net Operating Assets | -- | -- | 502.70K | 501.60K | -- |
| Cash from Operations | -2.76M | -2.84M | -1.77M | -1.77M | -1.55M |
| Capital Expenditure | -2.40K | -2.40K | 1.00K | 1.00K | -2.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.40K | -2.40K | 1.00K | 1.00K | -2.10K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -14.90K | -14.90K | -24.00K | -24.00K | -20.70K |
| Issuance of Common Stock | 7.44M | 7.44M | 0.00 | 0.00 | 5.81M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -422.30K | -422.30K | 44.30K | 44.30K | -295.90K |
| Cash from Financing | 4.56M | 4.69M | 13.40K | 13.30K | 3.58M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.80M | 1.85M | -1.76M | -1.75M | 2.03M |